OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Glioblastoma Microenvironment and Invasiveness: New Insights and Therapeutic Targets
José I. Erices, Carolina Bizama, Ignacio Niechi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7047-7047
Open Access | Times Cited: 57
José I. Erices, Carolina Bizama, Ignacio Niechi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7047-7047
Open Access | Times Cited: 57
Showing 1-25 of 57 citing articles:
Glioblastoma Therapy: Past, Present and Future
Elena Obrador, Paz Moreno-Murciano, María Oriol‐Caballo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2529-2529
Open Access | Times Cited: 61
Elena Obrador, Paz Moreno-Murciano, María Oriol‐Caballo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2529-2529
Open Access | Times Cited: 61
Lipid-based nanoparticles to address the limitations of GBM therapy by overcoming the blood-brain barrier, targeting glioblastoma stem cells, and counteracting the immunosuppressive tumor microenvironment
Changhong Zhao, Xinshu Zhu, Jianmei Tan, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116113-116113
Open Access | Times Cited: 30
Changhong Zhao, Xinshu Zhu, Jianmei Tan, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116113-116113
Open Access | Times Cited: 30
Intrinsic and Microenvironmental Drivers of Glioblastoma Invasion
Emerson De Fazio, Matilde Pittarello, Alessandro Gans, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2563-2563
Open Access | Times Cited: 15
Emerson De Fazio, Matilde Pittarello, Alessandro Gans, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2563-2563
Open Access | Times Cited: 15
Betulinic Acid for Glioblastoma Treatment: Reality, Challenges and Perspectives
Sílvia Fernandes, Mariana Vieira, Cristina Prudêncio, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2108-2108
Open Access | Times Cited: 10
Sílvia Fernandes, Mariana Vieira, Cristina Prudêncio, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2108-2108
Open Access | Times Cited: 10
Nanostructured lipid carriers for enhanced batimastat delivery across the blood–brain barrier: an in vitro study for glioblastoma treatment
Miguel Horta, Paula Soares, Bruno Sarmento, et al.
Drug Delivery and Translational Research (2025)
Closed Access | Times Cited: 1
Miguel Horta, Paula Soares, Bruno Sarmento, et al.
Drug Delivery and Translational Research (2025)
Closed Access | Times Cited: 1
Recent progress in combination therapy of oncolytic vaccinia virus
Seyedeh Nasim Mirbahari, Miles Da Silva, Abril Ixchel Muñoz Zúñiga, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Seyedeh Nasim Mirbahari, Miles Da Silva, Abril Ixchel Muñoz Zúñiga, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Comprehensive analysis of l ncRNA ‐associated ceRNA network reveals novel potential prognostic regulatory axes in glioblastoma multiforme
Maryam Bazrgar, Seyed Amir Mirmotalebisohi, Mohsen Ahmadi, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 11
Open Access | Times Cited: 5
Maryam Bazrgar, Seyed Amir Mirmotalebisohi, Mohsen Ahmadi, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 11
Open Access | Times Cited: 5
Lipid Nanoparticles for Brain Tumor Theranostics: Challenges and Status
Navneet Kaur Mattu, Priyadarshi Gautam, Dibyani Nanda, et al.
Bioconjugate Chemistry (2024) Vol. 35, Iss. 9, pp. 1283-1299
Closed Access | Times Cited: 4
Navneet Kaur Mattu, Priyadarshi Gautam, Dibyani Nanda, et al.
Bioconjugate Chemistry (2024) Vol. 35, Iss. 9, pp. 1283-1299
Closed Access | Times Cited: 4
Glioblastoma Tumor Microenvironment: An Important Modulator for Tumoral Progression and Therapy Resistance
Ligia Gabriela Tătăranu, Șerban Turliuc, A. El Kamel, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 9, pp. 9881-9894
Open Access | Times Cited: 4
Ligia Gabriela Tătăranu, Șerban Turliuc, A. El Kamel, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 9, pp. 9881-9894
Open Access | Times Cited: 4
Photodynamic and Sonodynamic Therapy Synergy: Mechanistic Insights and Cellular Responses Against Glioblastoma Multiforme
Swati Sharma, Geetanjali B. Gone, Parikshit Roychowdhury, et al.
Journal of drug targeting (2024), pp. 1-23
Closed Access | Times Cited: 4
Swati Sharma, Geetanjali B. Gone, Parikshit Roychowdhury, et al.
Journal of drug targeting (2024), pp. 1-23
Closed Access | Times Cited: 4
Integrating machine learning with mendelian randomization for unveiling causal gene networks in glioblastoma multiforme
Lixin Du, Pan Wang, Xiangyun Qiu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Lixin Du, Pan Wang, Xiangyun Qiu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Emerging Approaches in Glioblastoma Treatment: Modulating the Extracellular Matrix Through Nanotechnology
Miguel Horta, Paula Soares, Catarina Leite Pereira, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 142-142
Open Access
Miguel Horta, Paula Soares, Catarina Leite Pereira, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 142-142
Open Access
3D In Vitro Glioma‐Neuron‐Astrocyte Biomimetic Composites Recapitulate Key Molecular Mechanisms Linked to Glioblastoma Multiforme Pathophysiology
Mateo S. Andrade Mier, Esra Türker, Jessica Faber, et al.
Advanced Functional Materials (2025)
Open Access
Mateo S. Andrade Mier, Esra Türker, Jessica Faber, et al.
Advanced Functional Materials (2025)
Open Access
Addressing the Blood-Brain Barrier: Overcoming Glioblastoma Drug Delivery
Ly Porosk, Ülo Langel
Methods in pharmacology and toxicology (2025), pp. 83-104
Closed Access
Ly Porosk, Ülo Langel
Methods in pharmacology and toxicology (2025), pp. 83-104
Closed Access
Natural Source of Drugs Targeting Central Nervous System Tumors—Focus on NAD(P)H Oxidoreductase 1 (NQO1) Activity
Nikola M. Stojanović, M Mitić, Jovan Ilić, et al.
Brain Sciences (2025) Vol. 15, Iss. 2, pp. 132-132
Open Access
Nikola M. Stojanović, M Mitić, Jovan Ilić, et al.
Brain Sciences (2025) Vol. 15, Iss. 2, pp. 132-132
Open Access
A2A receptor antagonist 4-(2-((6-Amino-9-ethyl-8-(furan-2-yl)-9H-purin-2-yl)amino)ethyl)phenol, a promising adenosine derivative for glioblastoma treatment
Akshaya Murugesan, Aleksei N. Smirnov, Anxo Vila Alonso, et al.
European Journal of Pharmaceutical Sciences (2025), pp. 107039-107039
Open Access
Akshaya Murugesan, Aleksei N. Smirnov, Anxo Vila Alonso, et al.
European Journal of Pharmaceutical Sciences (2025), pp. 107039-107039
Open Access
Spatial biology – unravelling complexity within the glioblastoma microenvironment
Stephen Robinson, Chrysa Filippopoulou, Simoni Besta, et al.
Trends in Molecular Medicine (2025)
Open Access
Stephen Robinson, Chrysa Filippopoulou, Simoni Besta, et al.
Trends in Molecular Medicine (2025)
Open Access
Unmasking the potential: mechanisms of neuroinflammatory modulation by oncolytic viruses in glioblastoma
Narimene Beder, Seyedeh Nasim Mirbahari, Mourad Belkhelfa, et al.
Exploration of Targeted Anti-tumor Therapy (2025)
Open Access
Narimene Beder, Seyedeh Nasim Mirbahari, Mourad Belkhelfa, et al.
Exploration of Targeted Anti-tumor Therapy (2025)
Open Access
Glioblastoma Tumor Microenvironment and Purinergic Signaling: Implications for Novel Therapies
Martina Bedeschi, Elena Cavassi, Antonino Romeo, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 385-385
Open Access
Martina Bedeschi, Elena Cavassi, Antonino Romeo, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 385-385
Open Access
Construction of an Extracellular Matrix–Related Risk Model to Analyze the Correlation Between Glioblastoma and Tumor Immunity
Jian Li, Hong Wei Pan, Yangyang Wang, et al.
BioMed Research International (2025) Vol. 2025, Iss. 1
Open Access
Jian Li, Hong Wei Pan, Yangyang Wang, et al.
BioMed Research International (2025) Vol. 2025, Iss. 1
Open Access
Amino acid metabolism in glioblastoma pathogenesis, immune evasion, and treatment resistance
Shriyansh Srivastava, Robab Anbiaee, Mohammad Houshyari, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Shriyansh Srivastava, Robab Anbiaee, Mohammad Houshyari, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Naringenin Exhibits Antiglioma Activity Related to Aryl Hydrocarbon Receptor Activity and IL-6, CCL2, and TNF-α Expression
Monique Reis de Santana, Deivison Silva Argolo, Irlã Santos Lima, et al.
Brain Sciences (2025) Vol. 15, Iss. 3, pp. 325-325
Open Access
Monique Reis de Santana, Deivison Silva Argolo, Irlã Santos Lima, et al.
Brain Sciences (2025) Vol. 15, Iss. 3, pp. 325-325
Open Access
Lipid-drug conjugates for the treatment of glioblastomas
Anas Islam, Ambareen Fatima Ahmed, Malay K. Das, et al.
Elsevier eBooks (2025), pp. 293-332
Closed Access
Anas Islam, Ambareen Fatima Ahmed, Malay K. Das, et al.
Elsevier eBooks (2025), pp. 293-332
Closed Access
Evolution of Preclinical Models for Glioblastoma Modelling and Drug Screening
Grace Thomas, Ruman Rahman
Current Oncology Reports (2025)
Open Access
Grace Thomas, Ruman Rahman
Current Oncology Reports (2025)
Open Access
Kinin B1 Receptor Agonist Enhances Blood-Brain Barrier Permeability in Healthy and Glioblastoma Environments
Carolina Batista, João Victor Roza Cruz, Michele Siqueira, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 591-591
Open Access
Carolina Batista, João Victor Roza Cruz, Michele Siqueira, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 591-591
Open Access
